In comparison, AOD-9604 appears to result in weight loss, primarily related to fat loss
"Prescribing Information for GLP-1 Receptor Agonists." FDA Drug Safety Communications and Label Updates
Even though patients are often taking the exact same drug at the same or slightly adjusted doses, what changes is how they want to buy it and the level of care associated with it, and I think this explains why many customers switch and migrate to simpler, more transactional services where they can get their medication without the ankle-monitor and simply get on with their lives
However, imaging cannot definitively distinguish between benign and malignant peripheral nerve tumors
Di Somma MM, Nuti S, Telford JL, Baldari CT
This distinction in approval status is significant for individuals considering their options for obesity treatment